Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Chronic obstructive pulmonary disease [[electronic resource] ] : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes
| Chronic obstructive pulmonary disease [[electronic resource] ] : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes |
| Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, 2008 |
| Descrizione fisica | 1 online resource (127 p.) |
| Disciplina | 616.2/4 |
| Altri autori (Persone) |
BarnesPeter J. <1946->
HanselT. T <1956-> (Trevor T.) KonOnn Min |
| Collana | Oxford respiratory medicine library |
| Soggetto topico |
Lungs - Diseases, Obstructive
Respiratory organs - Obstructions |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-19-174015-2
0-19-960727-3 1-283-58202-3 9786613894472 0-19-156355-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Abbreviations; 1 Global burden and natural history of COPD; 2 Pathology and molecular features of COPD; 3 Clinical features, spirometry, and lung function; 4 Imaging in COPD; 5 Smoking cessation; 6 Chronic medical therapy and the GOLD guidelines; 7 Management of acute exacerbations including non-invasive and invasive ventilation; 8 Pulmonary rehabilitation; 9 Long-term, ambulatory, and short-burst oxygen therapy in COPD; 10 Lung volume reduction, bullectomy, and lung transplantation; 11 Palliative care and end-of-life issues; Index; A; B; C; D; E; F; G; H; I; L; M; N
OP; R; S; T; V; W; X |
| Record Nr. | UNINA-9910452593803321 |
| Oxford ; ; New York, : Oxford University Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chronic obstructive pulmonary disease [[electronic resource] ] : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes
| Chronic obstructive pulmonary disease [[electronic resource] ] : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes |
| Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, 2008 |
| Descrizione fisica | 1 online resource (127 p.) |
| Disciplina | 616.2/4 |
| Altri autori (Persone) |
BarnesPeter J. <1946->
HanselT. T <1956-> (Trevor T.) KonOnn Min |
| Collana | Oxford respiratory medicine library |
| Soggetto topico |
Lungs - Diseases, Obstructive
Respiratory organs - Obstructions |
| ISBN |
0-19-174015-2
0-19-960727-3 1-283-58202-3 9786613894472 0-19-156355-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Abbreviations; 1 Global burden and natural history of COPD; 2 Pathology and molecular features of COPD; 3 Clinical features, spirometry, and lung function; 4 Imaging in COPD; 5 Smoking cessation; 6 Chronic medical therapy and the GOLD guidelines; 7 Management of acute exacerbations including non-invasive and invasive ventilation; 8 Pulmonary rehabilitation; 9 Long-term, ambulatory, and short-burst oxygen therapy in COPD; 10 Lung volume reduction, bullectomy, and lung transplantation; 11 Palliative care and end-of-life issues; Index; A; B; C; D; E; F; G; H; I; L; M; N
OP; R; S; T; V; W; X |
| Record Nr. | UNINA-9910779234503321 |
| Oxford ; ; New York, : Oxford University Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chronic obstructive pulmonary disease : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes
| Chronic obstructive pulmonary disease : (COPD) / / edited by Onn Min Kon, Trevor T. Hansel, Peter J. Barnes |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Oxford ; ; New York, : Oxford University Press, 2008 |
| Descrizione fisica | 1 online resource (127 p.) |
| Disciplina | 616.2/4 |
| Altri autori (Persone) |
BarnesPeter J. <1946->
HanselT. T <1956-> (Trevor T.) KonOnn Min |
| Collana | Oxford respiratory medicine library |
| Soggetto topico |
Lungs - Diseases, Obstructive
Respiratory organs - Obstructions |
| ISBN |
0-19-174015-2
0-19-960727-3 1-283-58202-3 9786613894472 0-19-156355-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Abbreviations; 1 Global burden and natural history of COPD; 2 Pathology and molecular features of COPD; 3 Clinical features, spirometry, and lung function; 4 Imaging in COPD; 5 Smoking cessation; 6 Chronic medical therapy and the GOLD guidelines; 7 Management of acute exacerbations including non-invasive and invasive ventilation; 8 Pulmonary rehabilitation; 9 Long-term, ambulatory, and short-burst oxygen therapy in COPD; 10 Lung volume reduction, bullectomy, and lung transplantation; 11 Palliative care and end-of-life issues; Index; A; B; C; D; E; F; G; H; I; L; M; N
OP; R; S; T; V; W; X |
| Record Nr. | UNINA-9910825208403321 |
| Oxford ; ; New York, : Oxford University Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tuberculosis in clinical practice / / Onn Min Kon, editor
| Tuberculosis in clinical practice / / Onn Min Kon, editor |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (378 pages) |
| Disciplina | 616.995 |
| Soggetto topico | Tuberculosis |
| ISBN | 3-030-75509-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- The Natural History of TB and Latent Infection -- The Natural History of M.tuberculosis Infection -- The Pathogen -- The Mtb Infection Cycle -- Transmission -- Primary Mtb Infection and Primary TB -- Latent Infection and Post-primary TB -- The Epidemiological Cycle of TB -- Early Diagnosis of Infectious TB and Outcomes of Active Case Finding -- LTBI Screening and TB Prevention -- Summary -- References -- Bacillus Calmette-Guérin (BCG) Vaccine -- History of BCG Vaccine -- Efficacy of the BCG Vaccine -- Policy and Delivery of BCG Immunisation in the UK -- Immunology of BCG -- BCG Protection Beyond TB -- Adverse Events due to BCG -- BCG Vaccine: Revaccination Strategies -- References -- Pulmonary, Pleural and Mediastinal TB: Clinical Aspects and Diagnosis -- Pulmonary Tuberculosis -- Clinical Presentation of Pulmonary TB -- Diagnostic Approach -- Imaging: Chest Radiographs and CT Scans -- Sputum -- Induced Sputum -- Bronchoscopy and Bronchoalveolar Lavage (BAL) -- Paediatric Specimens -- Other Diagnostic Techniques and Biomarkers for Pulmonary TB -- Pleural TB -- Clinical Presentation of Pleural TB -- Diagnostic Approach -- Imaging -- Sputum in Pleural TB -- Pleural Fluid -- Pleural Tissue -- Closed Pleural Biopsies -- Thoracoscopy -- Intrathoracic Mediastinal TB -- Clinical Presentation of Mediastinal TB -- Diagnostic Approach -- Imaging -- Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) -- References -- Extra Pulmonary Lymph Node, Abdominal and Pericardial Tuberculosis -- Extra Pulmonary Lymph Node Tuberculosis -- Epidemiology -- Clinical Features -- Diagnosis -- Treatment -- Abdominal Tuberculosis -- Introduction -- Clinical Features -- Peritoneal Tuberculosis -- Intestinal Tuberculosis -- Diagnosis -- Differentiating Intestinal Tuberculosis from Crohn's Disease -- Hepatobiliary Tuberculosis.
Pancreatic Tuberculosis -- Treatment -- Pericardial Tuberculosis -- Introduction -- Clinical Manifestations and Presentation -- Diagnosis -- Treatment -- References -- Spinal and Bone Tuberculosis -- Introduction -- Incidence -- Aetiology -- Spinal Tuberculosis -- Presentation of Spinal TB -- Investigation of Spinal TB -- Differential Diagnosis -- Presentation of Bone and Joint TB -- Investigation of Bone and Joint TB -- Differential Diagnosis -- Isolation Precautions -- Non-tuberculous Mycobacterium (NTM) and Multi Drug Resistant TB (MDR TB) -- Poncet's Disease -- Treatment of TB Osteomyelitis -- Non-pharmacological Treatment -- Surgical Intervention -- Outcomes and Long-Term Morbidity -- References -- Tuberculosis of the Central Nervous System -- Epidemiology -- Pathogenesis -- Clinical Features -- Prognosis -- Diagnosis -- CSF Examination -- Diagnostic Imaging -- Differential Diagnosis -- Drugs for Treatment of CNS Tuberculosis -- First Line TB Drugs in the Treatment of TB Meningitis -- Duration of Treatment for TB Meningitis -- Adjunctive Therapy for CNS Tuberculosis -- Additional Supportive Measures -- Management of Cerebral Tuberculomas -- HIV Treatment in the Setting of TBM and Tuberculomas -- Case Vignette -- Images -- References -- Tuberculosis in Renal Disease -- Introduction -- What Do We Mean by CKD? -- Incidence & -- Prevalence of LTBI & -- active TB in CKD -- Reasons for Susceptibility to Infection and Disease -- Screening -- Tuberculin Skin Test (TST) -- Interferon Gamma Release Assays (IGRA) -- When and How to Screen? -- Presentation of Active TB -- Diagnosis of Active TB -- Management of LTBI -- Chemoprophylaxis -- Management of Active TB -- Special Considerations when Treating TB in CKD Patients -- Haemodialysis -- Peritoneal Dialysis -- Post-Transplant -- Summary -- References -- Tuberculosis in Children and Adolescents. Introduction -- Diagnosis -- Household Contacts -- Children Presenting with Symptoms or Abnormal Investigations -- Radiology -- Chest Radiology -- Computed Tomography (CT) -- Other Radiology -- Microbiology -- Specimen Collection -- Laboratory Tests -- Histology -- Immunological Tests -- Clinical Diagnosis -- Novel Tests -- Treatment -- Treatment Regimens -- Adverse Effects and Monitoring -- Drug Interactions -- Follow up -- Adherence -- Future of Treatment -- Central Nervous System Disease -- HIV Co-infection -- Decision-Making around Tuberculosis Infection Treatment -- Immune-Based Tests -- Management of TB Infection -- Other Issues -- Infection Control -- Impact on School and Education -- Child Protection -- Conclusions -- References -- HIV and TB -- Introduction -- Epidemiology -- Risk Factors for Tuberculosis in HIV Infection -- Clinical Features and Diagnosis of TB in HIV Co-infection -- Diagnosis of Pulmonary TB in HIV -- Molecular Testing in Pulmonary TB -- Diagnosis of Extrapulmonary TB in HIV -- Pleural TB -- Central Nervous System TB -- Disseminated TB -- Treatment of active TB/HIV Co-infection -- Timing of ART Initiation -- Choice of ART Initiation in HIV/TB Co-infection -- Types of ART -- Drug-Drug Interactions in HIV/TB Co-infection -- Choice of ART Regimen in HIV/TB Co-infection -- Patients on Established ART -- Choice of TB Treatment in HIV/TB Co-infection -- TB IRIS -- Clinical Features and Diagnosis of TB IRIS -- Outcomes and Treatment of TB IRIS -- Diagnosis and Treatment of Latent TB Infection in HIV -- Drug Resistant TB in HIV -- References -- Radiology of Tuberculosis -- Introduction -- Imaging Tuberculosis: The Modalities -- Imaging Considerations in Pulmonary and Abdominal Tuberculosis -- Radiology of Pulmonary Parenchymal, Pleural and Nodal Tuberculosis (See Tables 1, 2, and 3). Intra-thoracic Lymph Nodal Tuberculosis (ITLNTB) -- Parenchymal TB -- Pleural TB -- Miliary TB -- Non-tuberculous Mycobacteria -- TB in the Immunocompromised Host & -- TB-IRIS -- Latent TB and Radiological Markers of Disease Activity (Table 2) -- Cardiac TB -- Role of Interventional Radiology in Management of TB -- Abdominal and Pelvic TB -- Peritoneal TB -- Gastrointestinal Tract TB -- Hepatic and Splenic TB -- Adrenal TB -- Genitourinary TB -- Bone and Joint TB -- Extra-spinal Bone and Joint TB -- Imaging of Intracranial Tuberculosis Infection (See Tables 4 and 5) -- General Imaging Considerations -- Intracranial Pathology -- Meningeal Disease -- Parenchymal Disease -- Complications -- Spinal Tuberculosis -- General Imaging Considerations -- Spinal Pathology -- Head & -- Neck Tuberculosis Infection -- CNS Tuberculosis in Immunodeficiency -- Role of F18 -fluorodeoxyglucose (F18-FDG) PET-CT in Tuberculosis (Table 6) -- References -- Laboratory Diagnostic Techniques -- Introduction -- Specimen Collection -- Microscopy -- Culture and Susceptibility Methods -- Molecular Diagnostics and Whole Genome Sequencing -- References -- Whole Genome Sequencing: Applications and Cluster Investigations -- Introduction -- Identification of TB Strains and Predicting Drug Susceptibility -- Background -- The Advancement with WGS -- Identifying Genetically Similar Isolates -- Background -- Typing Before WGS -- Patient Benefits from WGS Relatedness -- Public Health Benefits from WGS Relatedness -- New Clusters/Incidents -- Established Clusters/Outbreaks -- Transmission and Evolution of TB -- Laboratory Errors -- Conclusion -- References -- The Tuberculin Skin Test and the IFN-γ Release Assays -- Introduction -- LTBI Definition and Diagnosis -- TST -- New Version of TST -- IGRA. QuantiFERON Test: Interpretation of the QFT Values Within the Uncertainty Zone (IFN-γ Values: 0.2-0.7 IU/ml) -- Accuracy -- Indeterminate or Borderline Results in IGRAs -- Interpretation of Serial QFT Results -- Serial IFN-γ Assays -- New Experimental Tests -- LTBI: Who Does Need to Be Screened? -- Recent contacts -- Children -- Migrants -- HIV-Infected Individuals -- Subjects Exposed to Biological Therapy -- Chronic Kidney Disease, Organ Transplantation, Stem Cell Transplant, Diabetes -- Health Care Workers -- References -- TB Treatment and Complications -- Introduction -- Drug Regimens: Active Disease -- Standard Treatment Regimen -- Duration of Continuation Phase -- Modification of Drug Regimens, According to Drug Sensitivity -- Adjunctive Treatments -- Drug Regimens: Latent TB Infection (LTBI) -- Drug Doses and Routes -- Practical Considerations -- Drug Interactions -- Monitoring During Treatment -- Baseline Assessment -- Ongoing Monitoring -- Management of Complications -- GI Symptoms (Nausea, Vomiting, Poor Appetite, Abdominal Pain) -- Rashes -- Arthralgias -- Peripheral Neuropathy -- Neurotoxicity -- Drug Induced Liver Injury (DILI) -- Special Groups on First Line Regimen -- Pregnancy -- Renal Failure -- Liver Disease -- Elderly -- Alternative Drug Regimens -- Management of Treatment Interruptions -- Monitoring of Treatment Response -- Further Reading -- Multi-drug Resistant Tuberculosis Management -- Introduction, Background and Epidemiology -- Diagnosing a Case of Drug Resistant Tuberculosis -- Management of DR-TB -- Conclusion -- References -- Therapeutic Drug Monitoring in Tuberculosis -- Introduction -- When Should TDM Be Performed? -- Interpretation of TDM Data -- The Role of TDM on TB Treatment -- Alternative Drug Monitoring Methods -- Specific Drug Information -- Isoniazid -- Rifampicin -- Rifabutin -- Pyrazinamide -- Ethambutol. Fluoroquinolones. |
| Record Nr. | UNINA-9910508478503321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||